Alajmi Amani, Adlan Najwa, Lahyani Rahma
Department of Operations and Project Management, College of Business, Alfaisal Univercity, Riyadh 11533, Saudi Arabia.
Procedia CIRP. 2021;103:32-36. doi: 10.1016/j.procir.2021.10.004. Epub 2021 Oct 20.
Covid-19 pandemic has affected global supply chains disrupting local inventory management. Multiple studies have shed light on the scarcity of personal protective equipment. Still, not much data was seen on how this crisis resulted in the disruption of other health care sectors. This paper studies how this crisis affected supply chains and inventory management on the laboratory commodities during the Covid-19 pandemic within Saudi Arabia. A cross-sectional qualitative study targeting laboratory personals and suppliers in Saudi Arabia is conducted to evaluate laboratory material inventory management. Our sample includes twelve hospitals and ten suppliers. The study revealed that the supply chain functions resilience was moderate to mildly affected during the pandemic. The higher effect in the supply chain functions was in the lead time (58%), followed by purchasing (33%), then the inventory (25 %). The actual lab supply was significantly affected in 2 hospitals only, moderately affected in 7 hospitals (58%), and mildly affected in 2 hospitals. The unavailability of reagents was the highest result of the disruption (50%) besides the price change and lack of alternatives. Almost (86 %) of suppliers reported that their service was partially affected in most supply chain functions although they claimed having reasonable resilience measures/processes to sustain their operations. The highest risk mitigation process were the backup supply, recovery plan, and emergency/disaster agreements coverage. Most than half of the organizations reported that they have mature resilience measures. This leads us to conclude that both laboratory and supplier inventory and supply chain management had reasonable resilience processes in Saudi Arabia. Those measures were clear in minimizing the disruption effects caused by the pandemic and having a moderate impact on the laboratory operations.
新冠疫情影响了全球供应链,扰乱了当地的库存管理。多项研究揭示了个人防护装备的短缺情况。然而,关于这场危机如何导致其他医疗保健部门中断的相关数据却不多。本文研究了在沙特阿拉伯,这场危机在新冠疫情期间是如何影响实验室用品的供应链和库存管理的。针对沙特阿拉伯的实验室工作人员和供应商开展了一项横断面定性研究,以评估实验室物资库存管理情况。我们的样本包括12家医院和10家供应商。研究表明,疫情期间供应链功能的恢复能力受到了中度至轻度的影响。供应链功能受影响较大的是交货时间(58%),其次是采购(33%),然后是库存(25%)。实际的实验室供应仅在2家医院受到显著影响,7家医院受到中度影响(58%),2家医院受到轻度影响。除了价格变化和缺乏替代品外,试剂供应不足是中断造成的最主要后果(50%)。几乎(86%)的供应商报告称,尽管他们声称有合理的恢复能力措施/流程来维持运营,但他们的服务在大多数供应链功能中都受到了部分影响。最高的风险缓解流程是备用供应、恢复计划以及应急/灾难协议覆盖范围。超过一半的组织报告称他们有成熟的恢复能力措施。这使我们得出结论,在沙特阿拉伯,实验室和供应商的库存及供应链管理都有合理的恢复能力流程。这些措施在将疫情造成的干扰影响降至最低以及对实验室运营产生适度影响方面是明确有效的。